Becton, Dickinson and Company (BDX) to Issue Quarterly Dividend of $1.05 on December 31st

Becton, Dickinson and Company (NYSE:BDX) declared a quarterly dividend on Thursday, November 6th. Shareholders of record on Monday, December 8th will be given a dividend of 1.05 per share by the medical instruments supplier on Wednesday, December 31st. This represents a c) annualized dividend and a yield of 2.4%. The ex-dividend date is Monday, December 8th. This is a 1.0% increase from Becton, Dickinson and Company’s previous quarterly dividend of $1.04.

Becton, Dickinson and Company has increased its dividend payment by an average of 0.0%per year over the last three years and has increased its dividend annually for the last 53 consecutive years. Becton, Dickinson and Company has a payout ratio of 28.3% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Becton, Dickinson and Company to earn $15.64 per share next year, which means the company should continue to be able to cover its $4.16 annual dividend with an expected future payout ratio of 26.6%.

Becton, Dickinson and Company Stock Performance

Shares of NYSE:BDX opened at $177.88 on Friday. The firm’s 50 day simple moving average is $186.77 and its 200 day simple moving average is $182.42. The company has a market capitalization of $50.99 billion, a price-to-earnings ratio of 31.99, a P/E/G ratio of 1.42 and a beta of 0.25. Becton, Dickinson and Company has a fifty-two week low of $162.29 and a fifty-two week high of $251.99. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.10 and a quick ratio of 0.62.

Becton, Dickinson and Company (NYSE:BDX) last released its quarterly earnings data on Thursday, April 14th. The medical instruments supplier reported $4.10 EPS for the quarter. The business had revenue of $5.32 billion during the quarter. Becton, Dickinson and Company had a net margin of 7.51% and a return on equity of 16.23%. As a group, sell-side analysts forecast that Becton, Dickinson and Company will post 14.43 earnings per share for the current year.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.